398 related articles for article (PubMed ID: 33149616)
1. Metformin Combined with 4SC-202 Inhibited the Migration and Invasion of OSCC via STAT3/TWIST1.
He Y; Fan Z; He L; Zhang C; Ping F; Deng M; Liu S; Wang Y; Cheng B; Xia J
Onco Targets Ther; 2020; 13():11019-11029. PubMed ID: 33149616
[TBL] [Abstract][Full Text] [Related]
2. Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma.
He Y; Tai S; Deng M; Fan Z; Ping F; He L; Zhang C; Huang Y; Cheng B; Xia J
Cancer Med; 2019 Jul; 8(7):3479-3490. PubMed ID: 31025540
[TBL] [Abstract][Full Text] [Related]
3. 4sc-202 and Ink-128 cooperate to reverse the epithelial to mesenchymal transition in OSCC.
Yang X; Sun T; Zhao Y; Liu S; Liang X
Oral Dis; 2022 Nov; 28(8):2139-2148. PubMed ID: 33772986
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.
Cao M; Tian K; Sun W; Xu J; Tang Y; Wu S
Exp Ther Med; 2022 Jan; 23(1):97. PubMed ID: 34976139
[TBL] [Abstract][Full Text] [Related]
5. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
6. Oct4 downregulation-induced inflammation increases the migration and invasion rate of oral squamous cell carcinoma.
Sun S; Yang H; Wang F; Zhao S
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1440-1449. PubMed ID: 34553218
[TBL] [Abstract][Full Text] [Related]
7. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
9. LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p.
Dai D; Feng XD; Zhu WQ; Bao YN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10313-10323. PubMed ID: 31841186
[TBL] [Abstract][Full Text] [Related]
10. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
Duan Q; Xu M; Wu M; Zhang X; Gan M; Jiang H
Cancer Med; 2020 May; 9(9):3115-3129. PubMed ID: 32130788
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
13. ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.
Qu Y; He Y; Yang Y; Li S; An W; Li Z; Wang X; Han Z; Qin L
J Cancer; 2020; 11(9):2621-2631. PubMed ID: 32201532
[No Abstract] [Full Text] [Related]
14. Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway.
Yin W; Liu Y; Liu X; Ma X; Sun B; Yu Z
Oncol Lett; 2021 Jan; 21(1):31. PubMed ID: 33262823
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LINC00662 promotes proliferation and migration in oral squamous cell carcinoma.
Xu D; Chen Y; Yuan C; Zhang S; Peng W
Onco Targets Ther; 2019; 12():647-656. PubMed ID: 30705593
[TBL] [Abstract][Full Text] [Related]
16. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
17. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
18. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
19. IRF2-induced Claudin-7 suppresses cell proliferation, invasion and migration of oral squamous cell carcinoma.
Li X; Yang W
Exp Ther Med; 2022 Jan; 23(1):7. PubMed ID: 34815759
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
